How can I manage hyperkalemia when only a glucose (dextrose) solution is available?

Managing Hyperkalemia with Glucose Solution Alone

Yes, glucose (dextrose) solution alone can effectively manage hyperkalemia by stimulating endogenous insulin release, which drives potassium into cells—this approach is explicitly recognized in pediatric emergency guidelines and is particularly effective in non-diabetic patients. 1

Evidence for Glucose-Only Therapy

The American Academy of Pediatrics guidelines specifically state that "glucose alone is effective" for hyperkalemia treatment 1. The mechanism relies on your patient's pancreas producing insulin in response to the glucose load, which then shifts potassium intracellularly.

Dosing Protocol

Based on guideline recommendations 1:

For Pediatric Patients:

• IV/IO: 0.5–1.0 g/kg of dextrose
• Alternative: 200 mg/kg as D10W only

Practical volumes by concentration:

• D10W: 5–10 mL/kg (for 0.5–1.0 g/kg dose)
• D25W: 2–4 mL/kg (for 0.5–1.0 g/kg dose)
• D50W: 1–2 mL/kg (for 0.5–1.0 g/kg dose)

Critical caveat: D50W is irritating to veins; dilution to 25% dextrose is desirable 1.

Administration Strategy

Initial Bolus Approach

Administer a concentrated dextrose bolus (as above) to rapidly stimulate endogenous insulin secretion. This triggers the intracellular potassium shift needed to lower serum potassium.

Continuous Infusion for Sustained Effect

Follow with constant infusion of D10W-containing IV fluids with appropriate maintenance electrolytes at a rate of 100 mL/kg per 24 hours (7 mg/kg per minute) 1. Older children may require substantially lower doses.

Critical Monitoring Requirements

Glucose, sodium, and potassium levels should be monitored carefully 1:

• Titrate the rate to achieve normoglycemia, because hyperglycemia has its own adverse central nervous system effects 1
• Monitor for rebound hypoglycemia—depending on etiology, hypoglycemia may recur 1
• Recent evidence shows rapid and repeated administration of 50% dextrose has been associated with cardiac arrest and paradoxical hyperkalemia 2

Important Caveats and Pitfalls

When Glucose-Only May Be Less Effective

1. Diabetic patients: Those with impaired pancreatic function may not produce adequate endogenous insulin in response to glucose
2. Severe hyperkalemia with ECG changes: May require additional cardioprotective measures (calcium) even if you cannot give insulin
3. Rate of administration matters: Avoid rapid boluses of concentrated dextrose—this can cause complications 2

Avoid Overcorrection

The rate of dextrose administration should be controlled to prevent:

• Severe hyperglycemia (which can worsen outcomes)
• Osmotic complications from rapid glucose shifts
• Paradoxical worsening of hyperkalemia from too-rapid administration 2

Comparison to Standard Insulin-Dextrose Therapy

While traditional teaching emphasizes insulin-dextrose combinations (ratio of 1 unit insulin for every 4 g glucose) 1, emerging evidence suggests glucose-only therapy may reduce hypoglycemia risk while maintaining efficacy 3. A recent trial protocol specifically investigates whether glucose-only therapy offers comparable potassium-lowering effects with reduced hypoglycemia risk, particularly in non-diabetic patients 3.

Practical Algorithm

1. Verify true hyperkalemia (rule out pseudohyperkalemia from hemolysis)
2. Assess for ECG changes indicating cardiotoxicity
3. Administer dextrose bolus: 0.5–1.0 g/kg IV (use D25W or diluted D50W to minimize vein irritation)
4. Follow with continuous D10W infusion at 7 mg/kg/min with electrolytes
5. Monitor potassium hourly for first 2–4 hours
6. Monitor glucose closely: Check every 30–60 minutes initially, then hourly
7. Adjust infusion rate to maintain normoglycemia while continuing potassium-lowering effect
8. Address underlying cause of hyperkalemia concurrently

Additional Considerations

For sustained management: If only glucose is available long-term, you may need to use continuous infusions rather than bolus dosing to maintain steady endogenous insulin stimulation. The constant infusion approach at maintenance rates helps prevent both hyperglycemia and rebound hypoglycemia 1.

Patient selection: This approach works best in non-diabetic patients with intact pancreatic function who can mount an appropriate insulin response to glucose administration 3.